Stay updated with breaking news from Castleark Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CEO Adam S. Grossman sold 100,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $10.72, for a total value of $1,072,000.00. Following the sale, the chief executive officer now owns 2,081,475 shares of the […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $48.64, for a total transaction of $76,851.20. Following the sale, the director now directly owns 15,541 shares in the company, valued […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $48.64, for a total value of $76,851.20. Following the transaction, the director now directly owns 15,541 shares in the company, valued […]
Camping World Holdings, Inc. (NYSE:CWH – Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 7,860,000 shares, a growth of 6.9% from the April 30th total of 7,350,000 shares. Approximately 18.8% of the shares of the stock are sold short. […]
Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month […]